Acute and late toxicity in a randomized trial of conventional versus hypofractionated three-dimensional conformal radiotherapy for prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 79, Issue 4, 2011, Pages 1013-1021

  Arcangeli, Giorgio ^a   Fowler, Jack ^b   Gomellini, Sara ^a   Arcangeli, Stefano ^a   Saracino, Biancamaria ^a   Petrongari, Maria Grazia ^a   Benassi, Marcello ^a   Strigari, Lidia ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Acute toxicity; Conventional fractionation; High risk disease; Hypofractionated schedule; Late toxicity; Prostate tumors

Indexed keywords

ACUTE TOXICITY; CONVENTIONAL FRACTIONATION; HIGH-RISK DISEASE; HYPOFRACTIONATED SCHEDULE; LATE TOXICITY; PROSTATE TUMORS;

DISEASES; RADIOTHERAPY; THREE DIMENSIONAL; TUMORS;

TOXICITY;

ACUTE TOXICITY; ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER RADIOTHERAPY; CHRONIC TOXICITY; COMPARATIVE STUDY; COMPUTER ASSISTED RADIOTHERAPY; DISEASE SEVERITY; DOSIMETRY; FOLLOW UP; GASTROINTESTINAL TOXICITY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; RECTUM DISEASE; SEMINAL VESICLE; TREATMENT DURATION; URINARY TRACT DISEASE;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; DOSE FRACTIONATION; FOLLOW-UP STUDIES; GASTROINTESTINAL TRACT; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; SEMINAL VESICLES; TIME FACTORS; UROGENITAL SYSTEM;

EID: 79951953933     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.12.045     Document Type: Article

References (32)

1. G.W. Barendsen Dose fractionation, dose rate and iso-effect relationships for normal tissue responses Int J Radiat Oncol Biol Phys 8 1982 1981 1997 (Pubitemid 13167385)
2. D.J. Brenner Toward optimal external-beam fractionation for prostate cancer Int J Radiat Oncol Biol Phys 48 2000 315 316
3. D.J. Brenner, and E.J. Hall Fractionation and protraction for radiotherapy of prostate carcinoma Int J Radiat Oncol Biol Phys 43 1999 1095 1101 (Pubitemid 29144800)
4. G.M. Duchesne, and L.J. Peters What is the alpha/beta ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy Int J Radiat Oncol Biol Phys 44 1999 747 748 (Pubitemid 29284122)
5. J.F. Fowler, R.J. Chappell, and M.A. Ritter Is α/β for prostate tumors really low? Int J Radiat Oncol Biol Phys 50 2001 1021 1031
6. G.G. Steel Basic Clinical Radiobiology 2003 Arnold London
7. J.F. Fowler The linear-quadratic formula and progress in fractionated radiotherapy: A review Br J Radiol 62 1989 679 694 (Pubitemid 19194494)
8. J.F. Fowler, P.M. Harari, and F. Leborgne Acute radiation reactions in oral and pharyngeal mucosa: Tolerable levels in altered fractionation schedules Radiother Oncol 69 2003 161 168 (Pubitemid 37485875)
9. J.F. Fowler The radiobiology of prostate cancer including new aspects of fractionated radiotherapy Acta Oncol 44 2005 265 276 (Pubitemid 40904130)
10. A. Pollak, A.L. Hanlon, and E.M. Horwitz Dosimetry and preliminary acute toxicity in the first 1000 men treated for prostate cancer on a randomized hypofractionation dose escalation trail Int J Radiat Oncol Biol Phys 64 2006 518 526 (Pubitemid 43083441)
11. P. Kupelian, V.V. Thakkar, and D. Khuntia Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Long-term outcomes Int J Radiat Oncol Biol Phys 63 2005 1463 1468 (Pubitemid 41628043)
12. J.M. Martin, T. Rosewall, and A. Bayley Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinoma Int J Radiat Oncol Biol Phys 69 2007 1084 1089 (Pubitemid 47625844)
13. J.H. Coote, J.P. Wylie, and R.A. Cowan Hypofractionated intensity-modulated radiotherapy for carcinoma of the prostate: Analysis of toxicity Int J Radiat Oncol Biol Phys 74 2009 1121 1127
14. B.L. Madsen, L.A. Hsi, and H.T. Pham Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: First clinical trial results Int J Radiat Oncol Biol Phys 67 2007 1009 1105
15. F. Leborgne, and J. Fowler Late outcomes following hypofractionated conformal radiotherapy vs. standard fractionation for localized prostate cancer: A nonrandomized contemporary comparison Int J Radiat Oncol Biol Phys 74 2009 1441 1446
16. L. Strigari, G. Arcangeli, and S. Arcangeli Mathematical model for evaluating incidence of acute rectal toxicity during conventional or hypofractionated radiotherapy courses for prostate cancer Int J Radiat Oncol Biol Phys 73 2009 1454 1460
17. Arcangeli G, Saracino B, Gomellini S, et al. A prospective phase III randomized trial of hypofractionation vs. conventional fractionation in patients with high-risk prostate cancer. Int J Radiat Oncol Biol Phys. Epub ahead of print Jan. 2, 2010.
18. J.D. Cox, J. Stetz, and T.F. Pajak Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1995 1341 1346
19. J.J. Pavy, J. Denekamp, and J. Letschert Late effects toxicity scoring: the SOMA scale Int J Radiat Oncol Biol Phys 31 1995 1043 1049
20. M. Roach III, G. Hanks, and H. Thames Jr. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference Int J Radiat Oncol Biol Phys 65 2006 965 974
21. G. Sanguineti, S. Agostinelli, and F. Foppiano Adjuvant androgen deprivation impacts late rectal toxicity after conformal radiotherapy of prostate carcinoma Br J Cancer 86 2002 1843 1847
22. V. Landoni, B. Saracino, and S. Marzi A study of the effect of setup errors and organ motion on prostate cancer treatment with IMRT Int J Radiat Oncol Biol Phys 65 2006 587 594
23. N.A. Obuchowski Nonparametric analysis of clustered ROC curve data Biometrics 53 1997 567 578 (Pubitemid 27262219)
24. E.S. Venkatraman, and C. Begg A distribution-free procedure for comparing receiver operating characteristic curves from a paired experiment Biometrika 83 1996 835 848
25. R.W. Lloyd-Davies, C.D. Collins, and A.V. Swan Carcinoma of the prostate treated by radical external beam radiotherapy using hypofractionation: Twenty-two years' experience (1962-1984) Urology 36 1990 107 111 (Pubitemid 20239018)
26. J.E. Livsey, R.A. Cowan, and J.P. Wylie Hypofractionated conformal radiotherapy in carcinoma of the prostate: Five-year outcome analysis Int J Radiat Oncol Biol Phys 57 2003 1254 1259 (Pubitemid 37443962)
27. H. Lukka, C. Hayter, and J.A. Julian Randomized trial comparing two fractionation schedules for patients with localized prostate cancer J Clin Oncol 23 2005 6132 6138
28. E.E. Yeoh, R.J. Fraser, and R.E. McGowan Evidence of efficacy without increased toxicity for hypofractionated radiotherapy for prostate carcinoma: Early results of a phase III randomized trial Int J Radiat Oncol Biol Phys 55 2003 943 955 (Pubitemid 36286996)
29. G.A. Viani, E.J. Stefano, and S.L. Afonso Higher-than-conventional radiation doses in localized prostate cancer treatment: A meta-analysis of randomized, controlled trials Int J Radiat Oncol Biol Phys 74 2009 1405 1418
30. B.S. Teh, W.-Y. Mai, and B.M. Uhl Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: Acute toxicity and dose-volume analysis Int J Radiat Oncol Biol Phys 49 2001 705 712 (Pubitemid 32114105)
31. P.A. Kupelian, C.A. Reddy, and E.A. Klein Short course intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Preliminary results on late toxicity and quality of life Int J Radiat Oncol Biol Phys 51 2001 988 993 (Pubitemid 33026429)
32. P.C. O'Brien, C.I. Franklin, M.G. Poulsen Trans-Tasman Radiation Oncology Group Acute symptoms, not rectally administered sucralfate, predict for late radiation proctitis: Longer term follow-up of a phase III trial Int J Radiat Oncol Biol Phys 54 2002 442 449 (Pubitemid 35286810)